EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Isolupalbigenin as a multi-target natural scaffold targeting HER2, EGFR, IGF-1R, and BCL-2 in breast cancer: An integrated docking, molecular dynamics, and DFT study

Renukadevi Jeyavelkumaran, Jayasri Bantaram, Sanjay Valliappan

Current Proteomics · 2026-04 · 23 (2) · 100100

DOI: 10.1016/j.curpro.2026.100100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Proteomics, 2026-04. Verfasst von Renukadevi Jeyavelkumaran und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Jeyavelkumaran, R., Bantaram, J., & Valliappan, S. (2026). Isolupalbigenin as a multi-target natural scaffold targeting HER2, EGFR, IGF-1R, and BCL-2 in breast cancer: An integrated docking, molecular dynamics, and DFT study. Current Proteomics, 23(2), 100100. https://doi.org/10.1016/j.curpro.2026.100100

Vancouver

Jeyavelkumaran R, Bantaram J, Valliappan S. Isolupalbigenin as a multi-target natural scaffold targeting HER2, EGFR, IGF-1R, and BCL-2 in breast cancer: An integrated docking, molecular dynamics, and DFT study. Current Proteomics. 2026;23(2):100100. doi:10.1016/j.curpro.2026.100100

BibTeX
@article{Jeyavelkumaran2026,
  author = {Jeyavelkumaran, Renukadevi and Bantaram, Jayasri and Valliappan, Sanjay},
  title = {Isolupalbigenin as a multi-target natural scaffold targeting HER2, EGFR, IGF-1R, and BCL-2 in breast cancer: An integrated docking, molecular dynamics, and DFT study},
  journal = {Current Proteomics},
  year = {2026},
  volume = {23},
  number = {2},
  pages = {100100},
  doi = {10.1016/j.curpro.2026.100100}
}
Kostenlos starten →